RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing. Wilkins D, Wahlby Hamren U, Chang Y, Clegg LE, et al. Pediatrics 2024;154:e2024067174.

Read + Share

Amedeo Smart

Independent Medical Education

Wilkins D, Wahlby Hamren U, Chang Y, Clegg LE, et al. RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing. Pediatrics 2024;154:e2024067174.
PMID: 39350745